Rigel Pharmaceuticals Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

36.34 -1.14 (-3.04%) USD | NASDAQ | Jan 20, 16:00

36.23 -0.11 (-0.30%) Pre-Market: 08:23

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Nektar Therapeutics	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade